SEC Form 4 · accession 0001179110-17-006837
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carlos Alban
Officer — EVP, Commercial Operations
Period of report
May 4, 2017
Accepted (ET)
May 8, 2017 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | May 4, 2017 | S | 43,000 | $67.00 | D | 114,745 | D | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 40,442 | I | Maria Cristina Alban 2007 Declaration of Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
Remarks
This sale was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).